UK markets close in 3 hours 39 minutes

PODD Oct 2024 230.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
8.430.00 (0.00%)
As of 10:03AM EDT. Market open.
Full screen
Loading interactive chart…
  • Business Wire

    Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands

    ACTON, Mass., June 20, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Omnipod 5, compatible with both Dexcom G6 and Abbott FreeStyle Libre 2 Plus continuous glucose monitor (CGM) sensors, is now fully available in the U.K. and the Netherlands for individuals aged two years and older with type 1 diabetes. Omnipod 5 is the first and only tubeless automated insulin del

  • Business Wire

    Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates

    ACTON, Mass., June 20, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today made several exciting announcements regarding the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), including its availability in France with Dexcom G6 compatibility, as well as two updates for the U.S. market — the commencement of the Omnipod 5 with Dexcom G7 integration full commercial launch as well as

  • GuruFocus.com

    Insider Sale at Insulet Corp (PODD) by SVP & Chief Technology Officer Mark Field

    On June 14, 2024, Mark Field, Senior Vice President & Chief Technology Officer of Insulet Corp (NASDAQ:PODD), executed a sale of 1,500 shares of the company.